Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role
Affiliations
Affiliations
- Department of Pharmaceutical Sciences, College of Health Sciences, Public Authority for Applied Education and Training (PAAET), Kuwait, Kuwait, ma.alhussaini@hotmail.com.
Abstract
Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that can affect any part of the body. The management of the disease includes nonpharmacotherapy and pharmacotherapy.
Aim of the review: To provide an up-to-date review of the etiology, epidemiology, clinical features, diagnostic findings, and treatment options for SLE. METHODS DATA SOURCE: A PubMed search of English language journals using a combination of words--elderly, SLE, late onset SLE, etiology, screening, diagnosis, or treatment to identify original studies, guidelines, and reviews on SLE, SLE, late onset SLE published between 2000 and present. Overall, original studies, clinical reviews, references, and guidelines were obtained and evaluated on their clinical relevance. The literature included guidelines and considerations for the etiology, diagnosis, screening, and management of SLE, late onset SLE.
Results: SLE is a chronic autoimmune disorder, the exact etiology of which is unknown. SLE predominately affects younger women; however, it is reported to occur in up to 20 % of patients 50 years or older. In patients with SLE, nearly every system in the body is affected with varying degrees of severity ranging from subclinical to fatal. The hallmark feature of SLE is the production of autoantibodies directed primarily against nuclear antigens, but also against cytoplasmic components of cells.
Conclusion: The diagnosis of SLE is based on criteria set by the American College of Rheumatology. Management is individualized and depends on presenting symptoms and reducing the likelihood of permanent damage to organs and tissues.
Similar articles
Systemic lupus erythematosus: a review of the disease and treatment options.
Gurevitz SL, Snyder JA, Wessel EK, Frey J, Williamson BA.Consult Pharm. 2013 Feb;28(2):110-21. doi: 10.4140/TCP.n.2013.110.PMID: 23395811 Review.
Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.
Arnaud L, Mathian A, Boddaert J, Amoura Z.Drugs Aging. 2012 Mar 1;29(3):181-189. doi: 10.2165/11598550-000000000-00000.PMID: 22263748 Review.
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.
James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain MT, Arbuckle MR, Walker C, Dennis GJ, Merrill JT, Harley JB.Lupus. 2007;16(6):401-9. doi: 10.1177/0961203307078579.PMID: 17664230
Lalani S, Pope J, de Leon F, Peschken C; Members of CaNIOS/1000 Faces of Lupus.J Rheumatol. 2010 Jan;37(1):38-44. doi: 10.3899/jrheum.080957. Epub 2009 Dec 15.PMID: 20008925
McDougall JA, Helmick CG, Lim SS, Johnston JM, Gaddy JR, Gordon C, Ferucci ED.Lupus. 2018 Jun;27(7):1169-1176. doi: 10.1177/0961203318763529. Epub 2018 Mar 19.PMID: 29554837
KMEL References
References
-
- Arthritis Care Res (Hoboken). 2011 Sep;63(9):1224-32 - PubMed
-
- N Engl J Med. 2011 Dec 1;365(22):2110-21 - PubMed
-
- Lupus. 2011 Oct;20(11):1142-6 - PubMed
-
- Curr Rheumatol Rep. 2011 Aug;13(4):283-90 - PubMed
-
- J Clin Pathol. 2000 Jun;53(6):424-32 - PubMed
-
- Clin Rheum Dis. 1984 Aug;10(2):251-75 - PubMed
-
- J Rheumatol. 2000 Sep;27(9):2142-5 - PubMed
-
- Lupus. 2002;11(6):340-7 - PubMed
-
- Ann Rheum Dis. 2006 Jan;65(1):57-63 - PubMed
-
- Lancet. 2007 Feb 17;369(9561):587-96 - PubMed
-
- Md State Med J. 1983 Jun;32(6):439-41 - PubMed
-
- Arthritis Care Res (Hoboken). 2010 Nov;62(11):1515-26 - PubMed
-
- Lupus. 2010 Jan;19(1):13-9 - PubMed
-
- Lupus. 2011 Oct;20(11):1117-25 - PubMed
-
- Arthritis Rheum. 2008 Dec 15;59(12):1796-804 - PubMed
-
- Semin Arthritis Rheum. 2010 Feb;39(4):257-68 - PubMed
-
- J Immunol. 2011 Apr 15;186(8):4794-804 - PubMed
-
- J Rheumatol. 1995 Jul;22(7):1265-70 - PubMed
-
- J Allergy Clin Immunol. 2011 Feb;127(2):303-12; quiz 313-4 - PubMed
-
- Lupus. 2006;15(11):757-61 - PubMed
-
- J Immunol Methods. 2011 Jan 5;363(2):187-97 - PubMed
-
- Lupus. 2009 Nov;18(13):1181-5 - PubMed
-
- Drugs Aging. 2012 Mar 1;29(3):181-189 - PubMed
-
- Best Pract Res Clin Gastroenterol. 2010 Apr;24(2):121-32 - PubMed
-
- Curr Neuropharmacol. 2011 Sep;9(3):449-57 - PubMed
-
- Lancet. 2011 Feb 26;377(9767):721-31 - PubMed
-
- Expert Opin Drug Saf. 2004 Jul;3(4):273-8 - PubMed
-
- Circulation. 2004 Jul 27;110(4):399-404 - PubMed
-
- Arthritis Rheum. 1999 Sep;42(9):1785-96 - PubMed
-
- Lupus. 2009 Mar;18(3):257-63 - PubMed
-
- Cochrane Database Syst Rev. 2000;(2):CD000951 - PubMed
-
- Autoimmunity. 2007 Dec;40(8):613-7 - PubMed
-
- Medicine (Baltimore). 2010 Jul;89(4):227-235 - PubMed
-
- Curr Med Res Opin. 2009 Jun;25(6):1501-14 - PubMed
-
- Arthritis Care Res (Hoboken). 2012 Jan;64(1):2-8 - PubMed
-
- Health Soc Work. 2011 Nov;36(4):269-78 - PubMed
-
- Arthritis Rheum. 2011 Dec;63(12):3918-30 - PubMed
-
- J Rheumatol. 2010 Jan;37(1):38-44 - PubMed
-
- Arthritis Rheum. 1982 Nov;25(11):1271-7 - PubMed
-
- Am J Med. 2006 Aug;119(8):700-6 - PubMed
-
- Bull NYU Hosp Jt Dis. 2010;68(3):218-22 - PubMed
-
- N Engl J Med. 2011 Nov 17;365(20):1886-95 - PubMed
-
- Lupus. 1999;8(8):586-95 - PubMed
-
- Arch Dermatol Res. 2009 Jan;301(1):99-105 - PubMed
-
- Lupus. 2011 Dec;20(14):1518-25 - PubMed
-
- Ann Rheum Dis. 2010 Jan;69(1):20-8 - PubMed
-
- Lupus. 2009 Nov;18(13):1169-75 - PubMed
-
- Ann Rheum Dis. 2008 Feb;67(2):195-205 - PubMed
-
- Clin Ther. 2010 Apr;32(4):667-77 - PubMed
-
- Ther Adv Chronic Dis. 2010 Jul;1(4):163-75 - PubMed
-
- J Rheumatol. 2008 Nov;35(11):2152-8 - PubMed
-
- Drugs Aging. 2007;24(9):701-15 - PubMed
-
- Drug Saf. 1993 Feb;8(2):99-127 - PubMed
-
- Int J Rheum Dis. 2012 Feb;15(1):62-8 - PubMed
-
- Lupus. 2012 Feb;21(2):158-61 - PubMed
-
- Lupus. 2009 Oct;18(11):935-40 - PubMed
-
- J Chronic Dis. 1955 Jan;1(1):12-32 - PubMed
-
- Ann Rheum Dis. 1991 Oct;50(10):702-5 - PubMed
-
- J Autoimmun. 2005;25 Suppl:46-8 - PubMed
-
- Lupus. 2012 Mar;21(3):241-50 - PubMed